TNFRSF4 and neoplasm: These regulatory B cells often play a tumor-promoting role (61), yet OX40 activation skews B cell differentiation, selectively reducing intra-tumoral Breg frequency and relieving immunosuppression while potentiating antitumor humoral immunity (62, 63).